Background: Oxidative stress has been implicated in the pathogenesis of ageing and menopause, and can arise through the increased production of lipid peroxides and/or a deficiency of antioxidant defence.
Introduction
Reactive oxygen species (ROS) and lipid peroxides, which are produced by a free radical chain reaction, have been implicated in the pathogenesis of a variety of conditions, including atherosclerosis, 1 ageing 2,3 and the menopause. 4, 5 Oxidative stress can arise through the increased production of ROS and/or a de¢ciency of antioxidant defences. Antioxidant de¢ciencies can develop as a result of decreased antioxidant intake, decreased synthesis of enzymes with antioxidant activity, or increased antioxidant utilization. 6 Important plasma antioxidants appear to be ascorbic acid, a-tocopherol, protein sulphhydryl groups and caeruloplasmin. 7 An increase in the lipid peroxide concentrations in the serum of women who have undergone bilateral oophorectomy has been reported. 4 The increase in the concentration of lipid peroxide in the serum of female mice after bilateral oophorectomy is evidence for the antioxidant activity of female hormones. 4 Furthermore, hormone replacement therapy (HRT), especially oestrogen administration in postmenopausal women, has bene¢cial e¡ects on the highdensity:low-density lipoprotein (HDL:LDL) ratio. 8--12 Tibolone is a synthetic steroid with oestrogenic, androgenic and progestogenic properties. 13 However, there is no information about the e¡ects of tibolone on antioxidant status in postmenopausal women. This prompted us to investigate the concentrations of ascorbic acid, a-tocopherol, total thiol groups, caeruloplasmin, erythrocyte glutathione (GSH) and plasma lipid peroxide in menopausal women before and after tibolone administration and compare them with the concentrations measured in young premenopausal women.
Materials and methods
In all, 24 postmenopausal women and 24 premenopausal healthy controls of reproductive age were admitted to the study. Clinical data on postmenopausal and premenopausal women are included in Table 1 . At the Istanbul Medical Faculty's Gynaecology and Obstetric Department, postmenopausal women were selected according to the following criteria:
(1) Natural menopause occurred at least 12 months before the onset of the study; (2) Body mass index (BMI) lower than 30 kg/m 2 ;
(3) No exposure to steroid drugs; (4) No history of breast or genital tract malignancy; or hepatic, renal, vascular or endocrinological disease.
The age of postmenopausal women was 49.873.1 years (range 45--55 years); age at menopause was 45.272.5 years (range 37--54 years); and time since menopause was 50.5724.4 months (range 12--168 months). The age of premenopausal women was 32.272.7 years (range 19--38 years). Premenopausal women were multiparous and not taking oral contraceptives. Blood samples were drawn on days 5--6 of the follicular phase of the menstrual cycle. In addition, premenopausal women had no symptoms of oestrogen de¢ciency, no history of breast or genital tract malignancy, no exposure to steroids, and were free of hepatic, renal, vascular and endocrinological diease. All women were non-smokers, were not taking any form of vitamin supplementation and were not consuming alcohol. Postmenopausal women were treated with 2.5 mg/day tibolone for six months and were in their follicular phase of the arti¢cial HRT cycle (day 5--6) at the time of sampling. Venous blood samples were collected in heparinized tubes from the antecubital vein at 10:00 h after an overnight fast and centrifuged immediately at 1000 g for 10 min to remove the plasma and erythrocytes. Plasma (1mL) was mixed with 2 mL of 5% (w/v) tricholoroacetic acid and centrifuged at 1000 g. The supernatant was used for ascorbic acid analysis and the remaining plasma was frozen at À701C. After centrifugation, the erythrocytes were washed twice with 5 mL aliquots of physiological saline. After the second wash, the erythrocytes were kept at À701C until GSH estimation. Ascorbic acid was measured spectrophotometrically by means of copper (II) oxidation followed by condensation with 2,4-dinitrophenylhydrazine. 14 The intra-and inter-assay coe⁄cients of variation (CV) were 4.2% and 5.7%, respectively. Plasma was analysed for a-tocopherol using Brown's method 15 (intra-and inter-assay CVs 8.5% and 12%, respectively). Caeruloplasmin was measured spectrophotometrically 16 (intra-and inter-assay CVs 5.5% and 7.7%, respectively). Determination of plasma thiol groups was performed according to the Sedlac and Lindsay method 17 (intra-and inter-assay CVs 4% and 4.5%, respectively). Erythrocyte GSH was assayed using the Beutler et al. 18 method (intra-and inter-assay CVs 4.8% and 5%, respectively). Plasma lipid peroxidation was evaluated as the concentration of thiobarbituric acid reactive substances (TBARS) using a malondialdehyde (MDA) standard --the Buege and Aust 19 method (intra-and inter-assay CVs 7% and 9%, respectively). Data were given as means plus and minus standard deviation (SD). The paired student's t-test was used to assess di¡erences in analyte concentrations in postmenopausal women before and after tibolone treatment. The unpaired t-test was used to evaluate differences between premenopausal and postmenopausal women. Correlations were evaluated by the Pearson correlation test. Table 2 shows the concentrations of plasma ascorbic acid, a-tocopherol, total thiols, caeruloplasmin, erythrocyte GSH and MDA in premenopausal controls, postmenopausal women before tibolone treatment and postmenopausal women after tibolone treatment. The concentrations of plasma ascorbate, a-tocopherol, total thiols and erythrocyte GSH in postmenopausal women before and after tibolone treatment were signi¢cantly lower than they were in premenopausal women. There was no signi¢cant di¡erence in mean plasma caeruloplasmin concentration between controls and postmenopausal women (before and after treatment). Plasma MDA concentrations in postmenopausal women not receiving tibolone were elevated compared with premenopausal women. It was found that there is a significant increase in concentrations of a-tocopherol and a decrease of lipid peroxide in postmenopausal women after six months of tibolone treatment. There was no correlation between age and estimated parameters in controls and menopausal women (before and after treatment).
Results

Discussion
The present study has shown that the menopause is associated with an increase in plasma lipid peroxidation. Some investigators have reported that plasma lipid peroxide concentrations increase in the serum of women and female mice following bilateral oophorectomy, 4,5 supporting a possible antioxidant role for female hormones. Also, oophorectomy of female rats results in a decrease in amounts of liver and adrenal vitamin E, and this decrease could be prevented by administering physiological doses of oestrogen. 20 There may be a inverse correlation between lipid peroxidation and antioxidant concentrations. 8, 21 Vitamin E, ascorbic acid, caeruloplasmin and plasma total thiol groups appear to be important plasma antioxidants. 7 In our study, we found a signi¢cant decrease in plasma ascorbic acid, a-tocopherol, total thiols and erythrocyte GSH concentrations in postmenopausal compared to premenopausal women. These observed di¡erences may be due to di¡erence in age. It has been reported that the antioxidant status of older patients and laboratory animals differs from that of younger ones, and that the di¡erences may arise through compensatory mechanisms. 2, 3 On the other hand, this decrease in antioxidant concentrations probably re£ects the increased consumption of these compounds by the increased oxidative stress (expressed as increased MDA concentration) seen following the menopause. What happens with plasma antioxidant defences and lipid peroxides after HRT? It has been reported that oestrogens act as antioxidants and inhibit the susceptibility of LDLs and HDLs to oxidative modi¢cation and favourably a¡ect lipid metabolism by reducing the number of LDL and increasing the number of HDL particles in plasma. 9--12 In the study by Mukai et al., 22 the antioxidant activity of oestrogens was evaluated by measuring the rates of reduction of substituted phenoxyl and tocopheroxyl radicals. It was observed that 2-hydroxyoestrone reacts rapidly with the tocopheroxyl radical to regenerate the substituted tocopherol. Interestingly, the rates of reaction with the tocopheroxyl radical were three orders of magnitude greater for 2hydroxyoestrone than for ascorbic acid. These results suggest the possibility that some oestrogens and forms of HRT have antioxidant activity in vivo and may function to preserve vitamin E concentrations through vitamin E regeneration. Furthermore, it has been shown that 2-hydroxyoestradiol and 2-hydroxyoestrone protect membrane phospholipids from lipid peroxidation better than some antioxidants, such as a-tocopherol. 11 Inal et al. have demonstrated that there is no signi¢cant di¡erence in the concentrations of lipid peroxides, superoxide dismutase and GSH peroxidase in postmenopausal women before and after HRT. In contrast, in those receiving HRT plus vitamin E, the concentration of lipid peroxides fell. 23 Tibolone appears to be at least as e¡ective as other forms of HRT in suppressing climacteric symptoms. 24, 25 Our results have shown that there is a significant increase in plasma a-tocopherol concentrations and decrease in concentrations from the tocopheroxyl radical of plasma lipid peroxide following tibolone treatment. Tibolone probably reacts similarly to 2-hydroxyoestrone to regenerate tocopherol. It may therefore exert antioxidant activity in vivo and may function to regenerate and therefore preserve vitamin E concentrations. 22 Another possible mechanism for the bene¢cial e¡ects of tibolone on antioxidant status is the e¡ect of tibolone on plasma lipid pro¢les. Tibolone may reduce concentrations of Lp(a) and triglyceride --parameters directly related to cardiovascular disease. Since high Lp(a) and triglyceride concentrations are associated with accentuated lipid peroxidation, decreased concentrations of Lp(a) and triglyceride may improve the antioxidant defence. 5, 13, 24 On the other hand, it is possible that the observed decrease of lipid peroxide and increased tocopherol values may re£ect better health care in postmenopausal women rather than an e¡ect directly related to tibolone.
In conclusion, the menopause is associated with increased oxidative stress, expressed as elevated concentrations of MDA and decreases in ascorbic acid, a-tocopherol, total thiols and erythrocyte GSH. Tibolone treatment probably acts by stimulating direct and indirect mechanisms of tocopherol regenerations and increasing plasma concentrations of vitamin E, resulting in a decrease in concentrations of plasma lipid peroxide. However, due to the relatively small number of women involved, this study can only be regarded as a pilot, and further studies performed on a larger scale are necessary to establish the exact mechanisms of tibolone in inhibiting oxidative stress in postmenopausal women.
